Hasil Pencarian - Andreas Engert

Perbaiki Hasil
  1. 1
    CD30-positive malignant lymphomas: time for a change of management?

    CD30-positive malignant lymphomas: time for a change of management? oleh Andreas Engert

    Diterbitkan 2013-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    The First Year of HemaSphere and Many More to Come

    The First Year of HemaSphere and Many More to Come oleh Andreas Engert, Jan Cools

    Diterbitkan 2018-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    The Fifth Year of HemaSphere

    The Fifth Year of HemaSphere oleh Jan Cools, Andreas Engert

    Diterbitkan 2021-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    THERAPY-RELATED MYELOID NEOPLASMS IN PATIENTS TREATED FOR HODGKIN LYMPHOMA

    THERAPY-RELATED MYELOID NEOPLASMS IN PATIENTS TREATED FOR HODGKIN LYMPHOMA oleh Dennis A Eichenauer, Andreas Engert

    Diterbitkan 2011-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    The Updated European Hematology Association Research Roadmap

    The Updated European Hematology Association Research Roadmap oleh Andreas Engert, Francesco Cerisoli, Jan Cools

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Introducing the HemaSphere Controversies Series

    Introducing the HemaSphere Controversies Series oleh Dennis A. Eichenauer, Jan Cools, Andreas Engert

    Diterbitkan 2019-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Open Access is the Plan S Way Forward in Hematology Research

    Open Access is the Plan S Way Forward in Hematology Research oleh Jan Cools, Andreas Engert, John Gribben, Elizabeth Macintyre

    Diterbitkan 2020-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    The emerging role of immune checkpoint inhibition in malignant lymphoma

    The emerging role of immune checkpoint inhibition in malignant lymphoma oleh Ida Hude, Stephanie Sasse, Andreas Engert, Paul J. Bröckelmann

    Diterbitkan 2017-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    THE CHEMOKINE CCL17/TARC AS A BIOMARKER IN HODGKIN LYMPHOMA

    THE CHEMOKINE CCL17/TARC AS A BIOMARKER IN HODGKIN LYMPHOMA oleh Maike Sauer, Sabine Ponader, Andreas Engert, Elke Pogge von Strandmann

    Diterbitkan 2013-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Pharmacokinetics of alemtuzumab in combination with fludarabine in patients with relapsed or refractory B-cell chronic lymphocytic leukemia

    Pharmacokinetics of alemtuzumab in combination with fludarabine in patients with relapsed or refractory B-cell chronic lymphocytic leukemia oleh Thomas Elter, Julia Kilp, Peter Borchmann, Holger Schulz, Michael Hallek, Andreas Engert

    Diterbitkan 2009-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Hodgkin’s Lymphoma and Paraneoplastic Phenomena in the Central Nervous System: A Case Report and Review of the Literature

    Hodgkin’s Lymphoma and Paraneoplastic Phenomena in the Central Nervous System: A Case Report and Review of the Literature oleh Marcus Vetter, Alexandar Tzankov, Andreas Engert, Matthias Mehling, Richard Herrmann, Christoph Rochlitz

    Diterbitkan 2011-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Controversies in the Treatment of Classical Hodgkin Lymphoma

    Controversies in the Treatment of Classical Hodgkin Lymphoma oleh Dennis A. Eichenauer, Marc André, Peter Johnson, Alexander Fossa, Olivier Casasnovas, Andreas Engert

    Diterbitkan 2018-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Affordability of Medicines a Top Priority for EHA: Toward a Fair Pricing Model for Innovative Medicines

    Affordability of Medicines a Top Priority for EHA: Toward a Fair Pricing Model for Innovative Medicines oleh Anton Hagenbeek, Andreas Engert, Peter Kapitein, Robin Doeswijk, On behalf of the EHA Task Force on Fair Pricing

    Diterbitkan 2017-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Bortezomib in combination with dexamethasone for patients with relapsed Hodgkin’s lymphoma: results of a prematurely closed phase II study (NCT00148018)

    Bortezomib in combination with dexamethasone for patients with relapsed Hodgkin’s lymphoma: results of a prematurely closed phase II study (NCT00148018) oleh Sven Trelle, Orhan Sezer, Ralph Naumann, Mathias Rummel, Ulrich Keller, Andreas Engert, Peter Borchmann

    Diterbitkan 2007-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    P063: Trial in Progress: Individualized Immunotherapy in Early-Stage Unfavorable Hodgkin Lymphoma - The Investigator-Initiated Phase II GHSG INDIE Trial

    P063: Trial in Progress: Individualized Immunotherapy in Early-Stage Unfavorable Hodgkin Lymphoma - The Investigator-Initiated Phase II GHSG INDIE Trial oleh Paul J. Bröckelmann, Helen Kaul, Michael Fuchs, Carsten Kobe, Christian Baues, Peter Borchmann, Andreas Engert

    Diterbitkan 2022-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Simvastatin-dependent apoptosis in Hodgkin’s lymphoma cells and growth impairment of human Hodgkin’s tumors in vivo

    Simvastatin-dependent apoptosis in Hodgkin’s lymphoma cells and growth impairment of human Hodgkin’s tumors in vivo oleh Bastian von Tresckow, Elke Pogge von Strandmann, Stephanie Sasse, Samir Tawadros, Andreas Engert, Hinrich P. Hansen

    Diterbitkan 2007-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    P038: HLA expression patterns of Hodgkin-Reed-Sternberg cells shape a spatially arranged tumor microenvironment in classical Hodgkin lymphoma

    P038: HLA expression patterns of Hodgkin-Reed-Sternberg cells shape a spatially arranged tumor microenvironment in classical Hodgkin lymphoma oleh Berit Müller-Meinhard, Sarah Reinke, Nicole Seifert, Andreas Engert, Paul J. Bröckelmann, Michael Altenbuchinger, Wolfram Klapper

    Diterbitkan 2022-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Suicide in European Hodgkin Lymphoma Patients

    Suicide in European Hodgkin Lymphoma Patients oleh Austin I. Kim, Helen Goergen, Andreas Engert, Ann S. LaCasce, Louise Maranda, Bruce Barton, Sven Borchmann

    Diterbitkan 2019-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Dendritic cell based tumor vaccination in prostate and renal cell cancer: a systematic review and meta-analysis.

    Dendritic cell based tumor vaccination in prostate and renal cell cancer: a systematic review and meta-analysis. oleh Andreas Draube, Nela Klein-González, Stefanie Mattheus, Corinne Brillant, Martin Hellmich, Andreas Engert, Michael von Bergwelt-Baildon

    Diterbitkan 2011-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    The Phase 3 Study ECHELON-1 Evaluating Brentuximab Vedotin in Patients With Newly Diagnosed Hodgkin Lymphoma Leaves Important Questions Unanswered

    The Phase 3 Study ECHELON-1 Evaluating Brentuximab Vedotin in Patients With Newly Diagnosed Hodgkin Lymphoma Leaves Important Questions Unanswered oleh Peter Borchmann, Alexander Fosså, Monika Długosz-Danecka, Boris Böll, Markus Dietlein, Carsten Kobe, Helen Goergen, Andreas Engert

    Diterbitkan 2018-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: